Intrinsic Value

Inhibikase Therapeutics, Inc. (IKT)

$2.16

-0.14 (-6.09%)

Enterprise Value -2,423.60
Net Debt -8.92
Equity Value -2,414.67
Shares Outstanding 5.33
Equity Value Per Share -452.77



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt